Status:
COMPLETED
Safety Study of AZT-04 for Cosmetic Use
Lead Sponsor:
Azitra Inc.
Collaborating Sponsors:
RCTs
Conditions:
Study of Three Doses of AZT-04 for Skin Appearance
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Double Blind, Three Cohort, Placebo-controlled Trial to Assess Safety, Tolerance and Induced Bacterial Colony Counts of Three Ascending Doses of AZT-04 in Healthy Adult Volunteers
Detailed Description
This is a single-center, prospective, double-blind, three cohort pilot study to assess the tolerability and induced changes in skin microbiome population and diversity of three ascending doses of test...
Eligibility Criteria
Inclusion
- Fluent in English, willing and able to read, understand, and sign the informed consent form
- Ability to complete the course of the study and comply with instructions
- Makes and Females ages 18-65 years, inclusively, in good general health as deemed by the investigator
- Individuals with Fitzpatrick skin type I, II, III, IV
- Individuals free of any systemic or dermatological disorder including a known history of allergies or other medical conditions which, in the opinion of the investigator, could interfere with the conduct of the study, interpretation of results or increase the risk of adverse reactions.
- Females practicing an acceptable method of birth control
Exclusion
- individuals with any visible skin disease, skin condition including baseline erythema assessment \> 0.5, or tattoos in the test area
- individuals with abnormal skin pigmentation at the test sites, which might interfere with subsequent evaluations of dermal responsiveness
- individuals with recent prolonged sun or tanning bed exposure in the test area
- individuals with excessive dryness or redness at the sites of application
- individuals with a known hypersensitivity to cosmetic or personal care formulations
- subjects must not have applied any lotions creams, powders, or oils to their backs the morning of the study. Additionally 2 hours must have passed since bathing or showering
- women who are pregnant or nursing
- individuals who have participated on a s study involving the test sites (back) in the previous 14 days
- individuals participating in another clinical study
- individuals with open or healing cuts/incisions abrasions, lesions, pustules, fissures or broken mucosa/skin in the test site
Key Trial Info
Start Date :
January 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03820076
Start Date
January 17 2019
End Date
July 31 2019
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RCTS, Inc.
Irving, Texas, United States, 75062